Fiduciary Trust’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-21,185
| Closed | -$39.2K | – | 640 |
|
|
2023
Q1 | $39.2K | Hold |
21,185
| – | – | ﹤0.01% | 610 |
|
|
2022
Q4 | $23.5K | Hold |
21,185
| – | – | ﹤0.01% | 620 |
|
|
2022
Q3 | $50K | Hold |
21,185
| – | – | ﹤0.01% | 600 |
|
|
2022
Q2 | $64K | Hold |
21,185
| – | – | ﹤0.01% | 617 |
|
|
2022
Q1 | $144K | Buy |
21,185
+3,463
| +20% | +$23.5K | ﹤0.01% | 650 |
|
|
2021
Q4 | $148K | Hold |
17,722
| – | – | ﹤0.01% | 645 |
|
|
2021
Q3 | $132K | Buy |
17,722
+4,492
| +34% | +$33.5K | ﹤0.01% | 637 |
|
|
2021
Q2 | $90K | Buy |
+13,230
| New | +$90K | ﹤0.01% | 630 |
|